Lv2
110 积分 2022-08-24 加入
First-in-human trial of the safety, pharmacokinetics and immunogenicity of a PEGylated anti-CD40L antibody fragment (CDP7657) in healthy individuals and patients with systemic lupus erythematosus
15小时前
已完结
Adverse Effects of Immunosuppression: Infections
12天前
已完结
Sequential immunotherapy: towards cures for autoimmunity
13天前
已完结
Telitacicept: First Approval
22天前
已完结
Trends in the drug target landscape for autoimmune diseases
22天前
已完结
Ianalumab, a Novel Anti-B-Cell Activating Factor (BAFF) Receptor (BAFF-R) Monoclonal Antibody (mAb) in Development for Immune Thrombocytopenia (ITP) and Warm Autoimmune Hemolytic Anemia (wAIHA), Has Demonstrated a Favorable Safety Profile in Sjögren's Syndrome (SjS), Systemic Lupus Erythematosus (SLE) and Chronic Lymphocytic Leukemia (CLL)
26天前
已完结
First-in-Human study of JNJ-55920839 in healthy volunteers and patients with systemic lupus erythematosus: a randomised placebo-controlled phase 1 trial
1个月前
已关闭
Burden of biliary tract carcinoma in China (1990–2021): Findings from the 2021 Global Burden of Disease Study
1个月前
已完结
Navigating First‐in‐Human and Early‐Phase Patient Studies: Study Designs, Risk Mitigation, and Population Selection Challenges
1个月前
已完结
Anti-BCMA and GPRC5D bispecific antibodies in relapsed/refractory primary plasma cell leukemia: a case report
1个月前
已完结
皖公网安备34019202002308
